Articles by admin

No Image

‘Sports Illustrated’ Is Sold Again, But Publishing Won’t Shift To New Owner Yet

Copies of the Sports Illustrated swimsuit issue for sale on a bookstore shelf Tuesday in New York City. Media company Meredith has announced that it has agreed to sell the magazine brand to entertainment company Authentic Brands Group for $110 million.

Drew Angerer/Getty Images


hide caption

toggle caption

Drew Angerer/Getty Images

Sports Illustrated has been sold for the second time in less than two years. This time, however, the $110 million purchase by Authentic Brands Group places far more importance on the iconic magazine’s reputation than the publication itself — pushing the name further into such ventures as gambling and live events.

The Meredith Corp. acquired Sports Illustrated in January 2018 along with a bunch of other titles as part of its purchase of Time Inc. Meredith moved to unload most Time Inc. magazines that were not focused on its primary audience: female readers. And those moves also reflected the flagging finances of major legacy publications.

So Meredith sold Time magazine to Salesforce co-founder Marc Benioff and his wife, Lynne Benioff; it dealt Fortune to a Thai entrepreneur, Chatchaval Jiaravanon, and it killed Money magazine’s print edition.

Sports Illustrated dominated sports journalism for decades, featuring the articles of such powerful writers as Frank Deford, George Plimpton and Gary Smith, and the photojournalism of such photographers as Neil Leifer. The magazine incorporated clear-eyed looks at civil and human rights, politics, power and money through the prism of professional, collegiate and amateur sport. A cover was considered a feat the equal to many accomplishments on the field of play.

Yet the immediacy of sports news, on cable television and online, in particular, from nimble and caustic websites to TV giant ESPN, chipped away at its seeming indispensability. So did larger societal shifts in how people consume information and news.

Sports Illustrated had so much residual goodwill among its readers and entire audience,” Terry McDonell, the former top editor over the magazine, tells NPR. “Everybody remembered something about sports in relationship to Sports Illustrated. I don’t think that’s gone away. It might have shrunk a bit.”

A Meredith spokeswoman says Sports Illustrated remains profitable with a 27-issue-per-year schedule. Yet the company has now sold Sports Illustrated to Authentic Brands in a deal that hinges on the acquisition of the magazine’s intellectual property. That includes its photo archive, its past sportsman and sportswoman of the year covers, and the annual swimsuit issues, which feature female models in bikinis — including supermodels from Cheryl Tiegs and Christie Brinkley in decades past to Tyra Banks.

“As a trailblazer and cultural phenomenon, Sports Illustrated has created moments and experiences for its readers that are unmatched by any other sports brand,” Nick Woodhouse, president and chief marketing officer of Authentic Brands, said in a statement. “We look forward to working with Meredith to extend Sports Illustrated’s legacy and connect the brand with new audiences around the world.

Authentic Brands also controls the rights to a wide array of brands, including such pop cultural figures as Marilyn Monroe and Elvis Presley; such sports figures as Julius Erving and Shaquille O’Neill; and such fashion lines as Juicy Couture.

Meredith will continue to publish the magazine and run its website for now — paying Authentic Brands a licensing fee to do so while maintaining editorial independence, according to both companies. Meredith’s president of national media said he would integrate SI‘s print and digital products into Meredith’s operations.

In a memo to staff, Sports Illustrated editor in chief Chris Stone wrote that the magazine would seek to reach greater audiences on other platforms — including in live events, conferences, gambling and video games. He also cited the development of television shows from SI material. And he praised Meredith for striking a deal that honored the magazine’s work.

“This deal only made sense if we continue to generate premium journalism and storytelling,” Stone said. The guarantee that the magazine would continue to publish under Meredith, however, lasts just two years.

Let’s block ads! (Why?)


No Image

Former Red Sox First Baseman Bill Buckner Dies At 69

Boston Red Sox first baseman Bill Buckner is shown in March 1986.

AP


hide caption

toggle caption

AP

Being remembered for a mistake is hard. Being the living symbol of 86 years of futility is just about impossible.

But that’s exactly what Bill Buckner was to Boston Red Sox fans for nearly 20 years.

Buckner, an All-Star and Gold Glove baseball player who played in the major leagues for 22 years, died Monday. He was 69.

“After battling the disease of Lewy Body Dementia, Bill Buckner passed away early the morning of May 27th surrounded by his family,” according to a statement from his family shared by the Red Sox. “Bill fought with courage and grit as he did all things in life. Our hearts are broken but we are at peace knowing he is in the arms of his Lord and Savior Jesus Christ.”

Buckner built up an impressive record as a player, with more than 1,000 runs scored during his career. He was an All-Star in 1981 while playing for the Chicago Cubs. But Buckner found it hard to shake a mistake he made during game six of the 1986 World Series against the New York Mets.

The Sox had a two-run lead, and were one strike away from winning their first World Series championship since 1918. But the Mets clawed back from the brink to tie the game in the 10th inning. With a runner on second base, a base hit would give the Mets the win and force a game seven.

It turns out they only needed the most famous error in baseball history.

YouTube

Mets player Mookie Wilson hit a grounder toward first base — as the announcer called it, “a little roller up along first.” Buckner ran toward the ball, took a wide stance, reached down to scoop it up — and the ball rolled right between his legs.

“It gets through Buckner!” the announcer says, shocked, as a Met crosses home plate. “The Mets win it!”

The error forced a game seven, which the Mets won. And the error turned Bill Buckner into New England’s scapegoat.

“People always ask me what I thought about when I missed the ground ball,” he told NPR in 2011. “My first thought was, ‘Wow, we get to play in the seventh game of the World Series … We’ll get ’em tomorrow.’ “

Buckner played for a few more years, retiring in 1990 and moving his family to Meridian, Idaho — where most people hadn’t heard of him, or his World Series gaffe. It wasn’t until 2004 that Buckner finally found redemption, once the Red Sox finally won their first World Series in 86 years.

Time and winning heal all sports wounds — and the fans and media were no longer so angry at Buckner. When Buckner returned to Fenway Park for the 2008 Red Sox home opener, he was greeted with open arms — and a two-minute ovation.

“It was awesome,” Buckner told NPR. “The real cool thing about it was the fans … were sincere,” he said. “I think they understood all the crap I went through, and they were always good to me.”

Perhaps the fans’ sentiment was best summed up by the the next day’s cover headline in the Boston Herald: “All is Forgiven.”

Let’s block ads! (Why?)


No Image

‘American Soil’ Is Increasingly Foreign Owned

A loaded combine during a late corn harvest in Hamilton, Ohio.

John Minchillo/AP


hide caption

toggle caption

John Minchillo/AP

American soil.

Those are two words that are commonly used to stir up patriotic feelings. They are also words that can’t be be taken for granted, because today nearly 30 million acres of U.S. farmland are held by foreign investors. That number has doubled in the past two decades, which is raising alarm bells in farming communities.

When the stock market tanked during the last recession, foreign investors began buying up big swaths of U.S. farmland. And because there are no federal restrictions on the amount of land that can be foreign-owned, it’s been left up to individual states to decide on any limitations.

It’s likely that even more American land will end up in foreign hands, especially in states with no restrictions on ownership. With the median age of U.S. farmers at 55, many face retirement with no prospect of family members willing to take over. The National Young Farmers Coalition anticipates that two-thirds of the nation’s farmland will change hands in the next few decades.

“Texas is kind of a free-for-all, so they don’t have a limit on how much land can be owned,” say’s Ohio Farm Bureau’s Ty Higgins, “You look at Iowa and they restrict it — no land in Iowa is owned by a foreign entity.”

Ohio, like Texas, also has no restrictions, and nearly half a million acres of prime farmland are held by foreign-owned entities. In the northwestern corner of the state, below Toledo, companies from the Netherlands alone have purchased 64,000 acres for wind farms.

There are two counties in this region with the highest concentration of foreign-owned farmland — more than 41,000 acres each. One of those is Paulding County, where three wind farms straddle the Ohio-Indiana line.

Higgins says that this kind of consumption of farmland by foreign entities is starting to cause concern. “One of the main reasons that we’re watching this … is because once a foreign entity buys up however many acres they want, Americans might never be able to secure that land again. So, once we lose it, we may lose it for good.”

His other concern is that every acre of productive farmland that is converted over to something other than agriculture, is an acre of land that no longer produces food. That loss is felt from the state level all the way down to rural communities, where one in six Ohioans has ties to agriculture.

Angela Huffman is a 6th-generation farmer in Wyandot County, which, along with Paulding County, has over 41,000 acres of foreign-owned farmland. Her modest, two-story white farmhouse has been in her family for almost 200 years. Her grandfather was the last person to actively farm the land here. When he got out of of farming due to declining markets, none of his five children wanted to take over, and the cropland is now leased.

But Huffman, a young millennial who lives here with her mother, wants to try to keep the farm going and revive her family heritage.

Walking out to the barn, a huge white Great Pyrenees dog watches over a small flock of sheep. Huffman says she’s worried about the effects of foreign land ownership on her rural community — which she describes as similar to Walmart pushing local businesses out of the market.

“Right out my back door here, Chinese-owned Smithfield Foods, the largest pork producer in the world, has recently bought out a couple grain elevators,” Huffman says, pointing across the field behind her house, “basically extracting the wealth out of the community.”

To be fair, U.S. farmers and corporations also invest in overseas agriculture, owning billions of dollars of farmland from Australia to Brazil, but the Smithfield Food buyout has really raised concerns with American farmers. As part of that 2013 sale, a Chinese company now owns 146,000 acres of prime U.S. farmland.

Back in the Huffman farmhouse, Joe Maxwell is typing on a laptop at the kitchen table. Maxwell is a fourth generation farmer from Missouri. He and Huffman are part of the Organization for Competitive Markets, an advocacy group of farmers and ranchers across the nation.

Maxwell points to the Smithfield Foods elevators across the field: “The money that those elevators used to make stayed within the community. Today the money those elevators make, will go into the pocket of someone thousands of thousands of miles away. This is going on across America.”

Maxwell is concerned that, as other states put restrictions on foreign purchases in place, Ohio in particular is being targeted. “So when they’re looking for investments in the U.S. and agriculture,” he says, “Ohio’s a great ag state and you don’t have any restrictions like other states.”

Nationwide, Canadian investors own the most farmland. In Ohio, it’s Germany, with 71,000 acres.

On the southern central part of the state, John Trimmer manages 30,000 acres of corn and soybeans for German investors. He’s been working with German families that have wanted to get into U.S. agriculture since the 1980s. “They started to buy land in Iowa and Minnesota,” Trimmer explains, “but right when they started, [Iowa and Minnesota] passed state laws which restricted foreign ownership.”

“None of them have an interest in the farm.”

Instead, the Germans turned to Ohio.

But, Trimmer says, there is a misconception about about foreign owners — that they aren’t good neighbors or good stewards of the land. What he sees is a growing divide between older family members who still live on the farm, and their children who have no interest in the family business and want to cash out the land.

“The last two farms we bought here, through an owner, her and her brothers and sisters inherited it from their mother, and none of them wanted to farm. None of them have an interest in the farm.” Trimmer explains that his German clients have established a reputation in the community for letting the tenants — often aging parents or grown children — continue to live in the houses on the farms they buy.

Sellers work directly with his German clients — instead of putting the property up on the market, the sale ensures that family members can live out their lives in the family homestead, while still getting cash value for the farmland.

Let’s block ads! (Why?)


No Image

Tylenol For Infants And Children Is The Same. Why Does 1 Cost 3 Times More?

Infants’ Tylenol comes with a dosing syringe, while Children’s Tylenol has a plastic cup. Both contain the same concentration of the active ingredient, acetaminophen.

Ryan Kellman/NPR


hide caption

toggle caption

Ryan Kellman/NPR

If you’ve ever had a little one at home with a fever, you might have noticed two options for Tylenol at the store.

There’s one for infants and one for children. They contain the same amount of medicine — 160 milligrams of acetaminophen per 5 milliliters of liquid — but the infant version costs three times more.

What gives? It turns out, there’s a backstory.

For decades, Infants’ Tylenol was stronger than the children’s version. The thinking was that you don’t want to give babies lots of liquid medicine to bring down a fever — so you can give them less if it’s stronger.

“It was three times more concentrated,” says Inma Hernandez of the University of Pittsburgh School of Pharmacy. Since it contained more acetaminophen, the active ingredient, she says, it made sense that it was also more expensive. “The price per milliliter was five times higher,” Hernandez says.

But there was a problem: Parents were making mistakes with dosing. Babies got sick — some even died. So in 2011, at the urging of the Food and Drug Administration, the maker of brand-name Tylenol, Johnson & Johnson, announced a change: Infants’ Tylenol would be the same concentration as Children’s Tylenol.

Now it’s the same medicine, but the price is still different.

A quick search online shows 4 ounces of Children’s Tylenol selling for $5.99, and Infants’ Tylenol also selling for $5.99, but for only 1 ounce of medicine. With many store brands of acetaminophen, it’s the same story: The infant version is generally three times more expensive than the one for children.

Kim Montagnino of Johnson & Johnson said in a statement to NPR that Infants’ Tylenol is more expensive because the bottle is more sturdy and it includes a dosing syringe, instead of a plastic cup. “These safety features of Infants’ Tylenol (dosing syringe, rigid bottle) are more expensive to manufacture than the dosing cup and bottle for Children’s Tylenol,” Montagnino wrote.

Hernandez doesn’t buy it.

“The cup versus the syringe doesn’t really explain the price difference in my opinion,” Hernandez says. “They’re really cheap because they’re just plastic. When we think of what’s expensive in a drug, it’s actually the active ingredient, and the preparation of that active ingredient in the formulation, not the plastic cup or the syringe.”

But Johnson & Johnson’s explanation makes sense to Edgar Dworsky, a consumer advocate and founder of the website Consumer World. “There’s an extra thing in the box, and extra things usually cost money,” he says.

“Think of a spray cleaner. You can buy the spray cleaner in the spray bottle, and that costs a little more money. Or you can buy the refill that gives you more ounces but it doesn’t have the sprayer on top — it’s kind of the same concept.”

But this, of course, is not a spray cleaner. It’s medicine. And parents are sensitive to marketing because the stakes are so high.

“I would certainly imagine that product-makers know that parents want to be very cautious when buying products for their kids,” Dworsky says. “Really, the lesson is — read the label. See what you’re getting for your money.”

Pediatrician Ankoor Shah at Children’s National Health System in Washington, D.C., knows how confusing all of this is for parents because he gets tons of questions from them about over-the-counter medications.

“The packaging and the dosing is not easy, it’s not simple and — personal opinion — it’s not parent-friendly,” Shah says.

For instance, Infants’ Tylenol doesn’t say on the label what the correct dosing is for a baby under age 2. It just says “ask a doctor.” Shah says he still uses a calculator to figure out how much to give a child, based on their weight, and gives slips to parents at kids’ well visits. You can also find the information from reputable sources online.

He says whether you opt for the Children’s or Infants’ bottle of acetaminophen at the store, the most important thing is to get the dosing right.

“When you start giving more acetaminophen than recommended, there are serious side effects that could happen,” he says.

The bottom line is: Know what you need. And if you need to spend that extra couple of dollars for the syringe and the special bottle to get the dosing just right, maybe the markup is worth it.


If you think you might have inadvertently overdosed a child, contact your doctor or call your local poison control center. There are 55 poison control centers across the U.S.; all of them can be reached at the same hotline number: 1-800-222-1222.

Let’s block ads! (Why?)


No Image

Olympic Track Star Rebukes Sponsorship Pay Penalties For Pregnant Athletes

NPR’s Michel Martin speaks with Olympic track runner Alysia Montano about how sport endorsement companies treat maternity leave.



MICHEL MARTIN, HOST:

Alysia Montano is an Olympian and a U.S. champion. You might remember her as the pregnant runner. She competed in 2014 when she was eight months pregnant with her first child. Two weeks ago, Montano made headlines again when, in a video for The New York Times, she called out the sports industry in general and sponsors like Nike and ASICS in particular for cutting off pay and health benefits to female athletes when they take time off to give birth and recover. That encouraged other women athletes to speak out about their experiences with sponsors. We called Montano to ask her to tell us more, starting with the financial realities of competing in track and field.

ALYSIA MONTANO: We’re not paid a huge salary by a league at all. Instead, our income comes almost exclusively from sponsorship deals with inked apparel companies, like Nike and ASICS, that keeps them bound for three to five years. And we don’t get rich.

MARTIN: No, point taken. Well, when you decided to have a baby, like, what happened? I mean, did you tell your contact at Nike? Did your agent speak to them? Like, what happened?

MONTANO: Back in 2012, I just finished the Olympic year. And I finished fifth at the Olympics. I noted hey, you know, you guys, it’s – I’m looking at my contract here, and there aren’t any protections in place. And they would not provide me with what would happen to me. That led us to kind of seeking out other options. ASICS came into play and kind of stated the same thing. Hey, I plan on expanding my family. ASICS at the time had said, we appreciate full athletes. Come over here. And so I did. I finished a year with them in which I finished with a bronze medal at world championships.

And so in that off-year, I’d hoped that we would conceive and be able to have our daughter and return to the sport. And I did conceive. I did have my daughter. And my daughter was two months old. And I got a phone call that said, I want to talk about your contracts in regard to your performance this year – which means – you mean the year that I’ve been with child? And then I was – my payment was reduced.

MARTIN: And what about your health benefits? I mean, that was another thing that emerged in the reporting on this is that there are athletes whose health insurance was terminated. And I can’t think a very thing – many things more frightening than either being pregnant or having a child or having a newborn with no health insurance – summarily terminated. So what about you? Did you at least have health insurance to cover the delivery or the postpartum period?

MONTANO: Yes. So the way that it works is a tier system. The luck that I did have with my daughter was I fell within the tier system because I made the Olympic team in 2012, and the protection was there for me. Now, if I didn’t make the Olympic team in 2012 and I became pregnant, I would lose my health insurance. My point and my stance is this should not be because I am an Olympian. This needs to be something that is in place for women athletes regardless.

MARTIN: I mean, this whole question of women and their reproductive choices is very much in the news right now. And I just have to ask you very directly, do you feel that you are getting messages from your sport that if you want to be a top-tier athlete, you should not have children?

MONTANO: Yes, absolutely. Before I had my daughter, I had a few examples of women that I looked up to who had returned to sport. I was very excited about – one of them being Kara Goucher. She talked about the difficult part of her motherhood and in resuming training and how she went on all these unpaid appearances with Nike. And her son ends up being extremely ill. And she, you know, she ends up having to leave him while he was dangerously ill to go compete at a race to restart her pay.

And that, to me, is a very strong message, like, your family is not first. Running and the sport is first regardless of – and also, we want you to prove to us, are you as focused, are you as dedicated? And the message is being sent that, if you’re a serious athlete, you do not want to be a mother, and motherhood is not for serious athletes.

MARTIN: Before we let you go, I do have to ask. There are those who will say it just isn’t their job. In fact, this is an argument that came up during the discussions over reauthorizing the Affordable Care Act or Obamacare. There were those who said during testimony well, you know, I’m a man, why should I pay for maternity benefits? It’s not my problem. It has nothing to do with me. So for people who feel that way, that, you know what, it’s a private decision, there isn’t any broader social responsibility to support this. You know, what would you say?

MONTANO: Of course that’s what somebody would say that. It’s oozing with privilege, right? When we look at women’s issues, women’s rights, this is a scope in which a man should not have any say on. And I think that it’s so asinine for people to – men in particular – to think, like, this is a personal issue. This is something that is true in the world. It’s – it can only happen to women. Men will never have to face pregnancy ever. And the people who are going to talk about policies and these protections are going to be men.

MARTIN: Is it true that all the people who negotiate these contracts at Nike are men?

MONTANO: They’re all men that are – within house at Nike have been and are all men. It’s an old boys club. The culture at Nike is – that’s – it remains to be an old boys club. And this is the time for it to be exposed. You know, the time is now.

MARTIN: That was Olympian and former USA champion Alysia Montano. Alysia Montano, thank you so much for talking to us.

MONTANO: Thank you so much for having me.

MARTIN: After we spoke with Montano, two news organizations reported that a Nike vice president, in a memo to staff, said the company was eliminating a performance requirement for 12 months for those athletes who decide to have a baby.

So we called Alysia Montano back to get her reaction. And she told us she wants to acknowledge movement on this issue, but she has not yet seen an actual contract. She says she wants to make sure Nike writes this protection into the contracts of new and current female athletes because, she says, track and field athletes tend to sign contracts before they are the age in which women typically start thinking about having families, and by the time they do, they are locked into contracts without protections for maternity leave.

Copyright © 2019 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.

Let’s block ads! (Why?)


No Image

Olympic Track Star Rebukes Sponsorship Pay Penalties For Pregnant Athletes

NPR’s Michel Martin speaks with Olympic track runner Alysia Montano about how sport endorsement companies treat maternity leave.



MICHEL MARTIN, HOST:

Alysia Montano is an Olympian and a U.S. champion. You might remember her as the pregnant runner. She competed in 2014 when she was eight months pregnant with her first child. Two weeks ago, Montano made headlines again when, in a video for The New York Times, she called out the sports industry in general and sponsors like Nike and ASICS in particular for cutting off pay and health benefits to female athletes when they take time off to give birth and recover. That encouraged other women athletes to speak out about their experiences with sponsors. We called Montano to ask her to tell us more, starting with the financial realities of competing in track and field.

ALYSIA MONTANO: We’re not paid a huge salary by a league at all. Instead, our income comes almost exclusively from sponsorship deals with inked apparel companies, like Nike and ASICS, that keeps them bound for three to five years. And we don’t get rich.

MARTIN: No, point taken. Well, when you decided to have a baby, like, what happened? I mean, did you tell your contact at Nike? Did your agent speak to them? Like, what happened?

MONTANO: Back in 2012, I just finished the Olympic year. And I finished fifth at the Olympics. I noted hey, you know, you guys, it’s – I’m looking at my contract here, and there aren’t any protections in place. And they would not provide me with what would happen to me. That led us to kind of seeking out other options. ASICS came into play and kind of stated the same thing. Hey, I plan on expanding my family. ASICS at the time had said, we appreciate full athletes. Come over here. And so I did. I finished a year with them in which I finished with a bronze medal at world championships.

And so in that off-year, I’d hoped that we would conceive and be able to have our daughter and return to the sport. And I did conceive. I did have my daughter. And my daughter was two months old. And I got a phone call that said, I want to talk about your contracts in regard to your performance this year – which means – you mean the year that I’ve been with child? And then I was – my payment was reduced.

MARTIN: And what about your health benefits? I mean, that was another thing that emerged in the reporting on this is that there are athletes whose health insurance was terminated. And I can’t think a very thing – many things more frightening than either being pregnant or having a child or having a newborn with no health insurance – summarily terminated. So what about you? Did you at least have health insurance to cover the delivery or the postpartum period?

MONTANO: Yes. So the way that it works is a tier system. The luck that I did have with my daughter was I fell within the tier system because I made the Olympic team in 2012, and the protection was there for me. Now, if I didn’t make the Olympic team in 2012 and I became pregnant, I would lose my health insurance. My point and my stance is this should not be because I am an Olympian. This needs to be something that is in place for women athletes regardless.

MARTIN: I mean, this whole question of women and their reproductive choices is very much in the news right now. And I just have to ask you very directly, do you feel that you are getting messages from your sport that if you want to be a top-tier athlete, you should not have children?

MONTANO: Yes, absolutely. Before I had my daughter, I had a few examples of women that I looked up to who had returned to sport. I was very excited about – one of them being Kara Goucher. She talked about the difficult part of her motherhood and in resuming training and how she went on all these unpaid appearances with Nike. And her son ends up being extremely ill. And she, you know, she ends up having to leave him while he was dangerously ill to go compete at a race to restart her pay.

And that, to me, is a very strong message, like, your family is not first. Running and the sport is first regardless of – and also, we want you to prove to us, are you as focused, are you as dedicated? And the message is being sent that, if you’re a serious athlete, you do not want to be a mother, and motherhood is not for serious athletes.

MARTIN: Before we let you go, I do have to ask. There are those who will say it just isn’t their job. In fact, this is an argument that came up during the discussions over reauthorizing the Affordable Care Act or Obamacare. There were those who said during testimony well, you know, I’m a man, why should I pay for maternity benefits? It’s not my problem. It has nothing to do with me. So for people who feel that way, that, you know what, it’s a private decision, there isn’t any broader social responsibility to support this. You know, what would you say?

MONTANO: Of course that’s what somebody would say that. It’s oozing with privilege, right? When we look at women’s issues, women’s rights, this is a scope in which a man should not have any say on. And I think that it’s so asinine for people to – men in particular – to think, like, this is a personal issue. This is something that is true in the world. It’s – it can only happen to women. Men will never have to face pregnancy ever. And the people who are going to talk about policies and these protections are going to be men.

MARTIN: Is it true that all the people who negotiate these contracts at Nike are men?

MONTANO: They’re all men that are – within house at Nike have been and are all men. It’s an old boys club. The culture at Nike is – that’s – it remains to be an old boys club. And this is the time for it to be exposed. You know, the time is now.

MARTIN: That was Olympian and former USA champion Alysia Montano. Alysia Montano, thank you so much for talking to us.

MONTANO: Thank you so much for having me.

MARTIN: After we spoke with Montano, two news organizations reported that a Nike vice president, in a memo to staff, said the company was eliminating a performance requirement for 12 months for those athletes who decide to have a baby.

So we called Alysia Montano back to get her reaction. And she told us she wants to acknowledge movement on this issue, but she has not yet seen an actual contract. She says she wants to make sure Nike writes this protection into the contracts of new and current female athletes because, she says, track and field athletes tend to sign contracts before they are the age in which women typically start thinking about having families, and by the time they do, they are locked into contracts without protections for maternity leave.

Copyright © 2019 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.

Let’s block ads! (Why?)


No Image

Why Suburban Moms Are Delivering Your Groceries

“I had one day, I worked six hours and made $50. It really wasn’t worth it. … But it doesn’t happen that often,” says Hilary Gordon, who works as a shopper for the grocery-delivery app Instacart in Sacramento, Calif. “The other day I worked 11-and-a-half hours and made $265. Great? No. But good.”

Alina Selyukh/NPR


hide caption

toggle caption

Alina Selyukh/NPR

At 6:30 am, four of five Gordon family members are roaming around their suburban Sacramento house — if you only count the humans. There’s also four dogs, a bunny, a tortoise, chickens, ducks, goats, and a not-so-miniature miniature pig named Squiggy.

Hilary Gordon is discussing the day’s schedule with her husband in the middle of wrapping a breakfast sandwich for their 14-year-old, checking on cereal for their 17-year-old, and staring down their 11-year-old who just realized he forgot to finish today’s math homework.

Having time like this with her family is a major reason why Gordon, 47, works as a shopper for the grocery-delivery app Instacart, in a suburb of Sacramento. “I find it fun. It gives me something to do, I’m not out spending money. And I love the flexibility,” she says.

Instacart is one of a slew of similar apps — DoorDash, Postmates, Shipt — paying tens of thousands of workers like Gordon to deliver packages, food or groceries to strangers. Similar to those who drive for rideshare apps Uber and Lyft, delivery workers can choose when to work. But they don’t have to invite strangers into their cars.

This draws women — often in their 40s and 50s — who now make up more than half of the contractors working for major food delivery apps.

Instacart told NPR more than 50% of people who shop for the app are women. DoorDash said women make up more than 50% of its “dashers” in rural and suburban areas, and more than 60% in urban areas. Target’s Shipt declined to share this statistic. Postmates said an April survey of its workers showed 48% were female, and 38% had a child at home.

Gordon and a half-dozen other women shared details of working for delivery apps to NPR, which paint a picture of the epitome of gig work: Accessible but high-intensity, with pay that’s quick but unpredictable and hours that are flexible but unreliable.

“I tell people, it’s a great thing to have, if you’re looking for extra money but you don’t really need it,” said Christina Lewkowitz, 50, who works for Instacart, DoorDash, Shipt, Deliv and a vineyard in Sacramento.

‘I will not work for free’

After splitting up school drop-offs with her husband, Hilary Gordon parks her Subaru SUV in a grocery store parking lot. Her Instacart shift today is 8 am to 6 pm. She’s got her shopping sneakers on and a fully charged phone — watching the screen for incoming grocery orders, which she will both shop and deliver.

The first “batch,” as they call it, is a bust: $8 with no tip, for seven items, to be taken 4 miles. But the store is 8 miles away. Instacart says it pays 60 cents per mile for delivery to the customer, but doesn’t pay for the drive to the store in the first place. The company explains that it can’t be sure that the worker, for example, isn’t doing a non-Instacart gig until they begin shopping.

Before accepting an orders, Gordon estimates the cost of gas for the drive to and from the store. She looks out for addresses known to require climbing stairs and very heavy items like a 50-pound bag of dog food or 13 cases of water.

Alina Selyukh/NPR


hide caption

toggle caption

Alina Selyukh/NPR

Logging miles is a big cost of the job. Some days Gordon might drive a hundred miles, filling up the tank at least once a day. For every order, she does quick math to calculate the gas expense. This $8 order doesn’t cut it. Gordon picks one of her canned responses to Instacart: “Pay too low. I will not work for free!”

“It’s really hard to say yes to that, because you feel like, then they’re thinking, ‘Oh, well, see, they’ll work for that’ — and I don’t want to work for that,” Gordon says.

But you can’t skip too many orders — the app will think you stopped working. Gordon gets a good one: eight items, for $9.87 plus a promise of a $6 tip. But most importantly, it’s only 1.5 miles of driving. She can knock it out in about 20 minutes.

Shopping for other people is a bit like a scavenger hunt, except the app is timing you. You rush through the whole store, scanning every item that goes in the basket and messaging the customer with updates.

Gordon checks each bell pepper for blemishes, throws a hail-mary on the ripeness of avocados, tells Instacart that “organic celery” is out of stock. The app suggests she grab “spring water” instead. Gordon laughs out loud.

After almost a year and a half with Instacart, Gordon says she still loves grocery shopping. And she especially loves meeting new people — chatting up store workers for help and playing with friendly pets she meets at customers’ homes.

‘Hopefully tomorrow is better’

Like a lot of gig workers, this is not a career Gordon pictured for herself. She has two master’s degrees — in counseling and family therapy.

She worked as a therapist in other states, but a move to California required more classes and exams, right as her oldest was born. Gordon became a social worker, until she made the calculation familiar to many working women: Her job took up mornings and evenings, with a not-so-great salary.

“When you’re going to pay the majority of it to let someone else raise your kids? Just didn’t make any sense,” Gordon says.

After a week off for college visits, Gordon is hustling to keep up the number of hours worked for Instacart. She has to log at least 90 hours in three weeks to get “early access” to the app’s schedule of shifts. It’s the only way she can get predictable and long enough hours to make the gig worth it for her.

Alina Selyukh/NPR


hide caption

toggle caption

Alina Selyukh/NPR

A few years later, the recession hit. Her husband lost his job in finance. Their house value dropped. They’re still paying down the debt that stacked up. But now, there’s also soccer, swim team, lacrosse, broken cleats, a junior prom dress, trips to look at colleges, AP exams, SAT tests and summer camp.

This rhythm is all-too familiar for women doing app work. Gigs help cover some expenses of child and health care — an opportunity for side-income on top of a steadier job, either the deliverer’s or their partner’s. Workers who do app-based jobs to supplement income is a growing cohort within the gig economy, says Shelly Steward of the Future of Work Initiative at the Aspen Institute.

Gig workers are often “independent contractors” who don’t get benefits like health insurance or sick leave. And when families piece together multiple jobs and gigs to make a living, “the system of workplace benefits that’s been in place does not adequately cover nearly as many workers,” Steward says.

Stacie Ballard, 43, pieces together work for at least seven apps while building her own business in Atlanta. She keeps a stack of t-shirts in her trunk — green for Instacart, green and white to walk dogs for Wag, green and grey to deliver packages for Shipt — changing between gigs as she earns extra cash for her teenager’s graduation and other expenses.

“If you’re a mom or a caregiver or something, it’s really flexible,” Ballard said. “It can be frustrating when you know you have certain bills that are coming up, and you’re like, ‘Ok, I need to make this much money. Hopefully tomorrow is better,’ But so far it’s always worked out.”

All the things to consider

Ballard, like many women in the gig economy, works for apps part time. For one, hustling full-time is exhausting. But also, hours can be hard to get.

On Instacart, available hour-long shifts get claimed within seconds, workers said. Part-time workers like Ballard and Lewkowitz often stalk the app all day, hoping to grab some.

Gordon is one of the Instacart regulars who gets “early access” to a full week’s worth of shifts so she can get hours predictable and long enough to make the work worth it for her. But to qualify, she commits to doing this “gig” full-time, because “early access” requires working at least 90 hours in three weeks or 25 hours in three weekends.

Instacart says it’s announced a pilot of a new way to qualify, which would encourage good customer ratings instead of long hours.

Even for full-timers like Gordon, signing up for shifts is “anxiety-inducing.” She describes frantic clicking on Sunday mornings, when the schedule opens, selecting all the hour-slots before they get claimed, within minutes.

And after all that, as any gig worker knows, having more hours doesn’t assure a huge paycheck bump. It might be a slow day, or long distances might make orders not worth the cost of gas. Workers also consider less obvious cost of these jobs. Is the order too complicated and time consuming? Too heavy?

Once, Gordon accidentally accepted a Costco batch with 81 cases of water. She says Instacart told her she could do multiple trips, but she refused and had to return — and ultimately give up — the whole order. So today, Gordon is eagle-eyed, spotting 13 cases of water in an otherwise appealing $32 batch.

One final thing she always checks is whether she knows the delivery address. Many delivery workers keep a mental track of locations that require climbing stairs, like apartments without elevators. On Gordon’s mental list are also a house with the guy who greeted her in a robe, and an older man who pressured her into bringing his groceries inside and said he’d been tracking her.

And then there’s the matter of tipping. Orders from businesses are notorious for being large and lacking tips. Workers say they wish the apps more aggressively encouraged their users to tip. Instacart recently changed its tipping system and retroactively compensated workers after workers and labor advocates fought a policy that counted tips toward base payments that Instacart promised for deliveries — sometimes offsetting what Instacart paid out of its own pocket.

Today, Gordon delivered eight orders in 10 hours, and made $133, before extra bumps for heavy orders and good reviews. Today was okay. There was one day when she made $50 in six hours. That wasn’t worth it. Gordon’s best day’s haul was $255 — when she worked almost 12 hours.

Let’s block ads! (Why?)


No Image

Saturday Sports: Stanley Cup, NBA Playoffs, Minnesota Twins

NPR’s Scott Simon talks with ESPN’s Howard Bryant about the Stanley Cup, the NBA and the Minnesota Twins making history.



SCOTT SIMON, HOST:

Time for sports.

(SOUNDBITE OF MUSIC)

SIMON: You got to suffer if you want to sing the blues. And the St. Louis Blues sure have. But after all these years, they’re in the Stanley Cup Finals. Also, who’ll face the fearless Golden State Warriors? And what about the Twins? Howard Bryant of ESPN joins us. Morning, Howard.

HOWARD BRYANT, BYLINE: Good morning, Scott.

SIMON: The Stanley Cup Finals between the Boston Bruins and the St. Louis Blues begin Monday. This is kind of Cinderella versus Godzilla.

BRYANT: (Laughter) In a way, they weren’t that far apart in terms of the regular season – only really a game. But in terms of history, absolutely. The St. Louis Blues have not been to the Stanley Cup since 1970, when they lost to the Boston Bruins – and the famous shot of Bobby Orr leaping through the air, giving the Bruins their first Stanley Cup since 1929, I think. It was just an amazing moment if you’re a Bostonian.

However, this is a – going to be a fun matchup. I really sort of enjoy what the Blues have done. And they – they’re so tough. They were down two games to one against San Jose. And then they just went on a tear. The Bruins are the hottest team in hockey. They’ve won seven straight. So you have this great clash.

And the Blues are just so tough. And they’re tough on the road. They play better on the road than they do at home. And I’m really looking forward to seeing what this matchup brings, especially the two lines – Tarasenko and Schwartz and this – these guys are playing really, really good hockey. I didn’t think they were going to take out the Sharks the way they did.

And on the other hand, of course, the Bruins – that Boston City just keeps winning championships in their top line in there – whether it’s Bergeron or Pastrnak or Marchand. And then, of course, they’ve got the hottest goalie in the world, as well, with Tuukka Rask. So it’s going to be a great matchup.

SIMON: OK. NBA Eastern Conference Final – Game Six tonight between the Toronto Raptors and Milwaukee Bucks.

BRYANT: (Laughter).

SIMON: My bleat of fear the deer may have…

BRYANT: You’re the jinx, Scott Simon.

SIMON: I – exactly.

BRYANT: You’ve ruined it for everybody.

SIMON: So I have a cheer for Toronto, OK? I want – the producer of our show is from Toronto. So I want to give him a good one. Ready for this? Abhor the dinosaur.

BRYANT: (Laughter).

SIMON: What do you think?

BRYANT: I think that’s terrible, Scott. I do.

SIMON: (Laughter).

BRYANT: I think we the north is so much more appropriate and fun. And, you know, when they made this deal last year – because trading DeMar DeRozan was not a popular move, considering that he felt lied to. He had committed to the organization. And then the organization then traded him to to San Antonio for Kawhi Leonard, who just happens to be one of the top three players in the game. It wasn’t a great move considering that you want to show loyalty.

And – but here’s the deal, Kawhi Leonard is that good. He’s been carrying this team. He’s been fantastic. He’s – between he and Kevin Durant – between Durant, Kawhi Leonard and LeBron James, they’re as good as it gets in the game. And when you watch Kawhi play basketball, he has carried this team to a place that they’ve never been. They’ve never been this close to the NBA Finals before.

And Milwaukee, meanwhile, they’ve got to win a basketball game. They’ve been the best team in basketball all season long record-wise. They won 60 games. And now they’re facing it.

Now they’re facing the adversity of having to go to Toronto on the road and winning a game to bring it back for a Game Seven. And at some point in the playoffs, you find out who you are. And the Milwaukee Bucks are going to find out when they get to Toronto.

SIMON: Let’s just note on our way out in just a few seconds, the Minnesota Twins have already hit 100 home runs this season. What are they eating for breakfast?

BRYANT: Spinach, like Popeye.

SIMON: (Laughter).

BRYANT: It’s incredible. I think they’ve got the best record in baseball. You’ve got guys you’ve never heard of – Rosario, Kepler – just hitting the ball out of the ballpark. And we’ll see if they’re built for 162. But right now, it’s the story in baseball. It’s a lot of fun.

SIMON: Howard Bryant, thanks so much.

BRYANT: Thank you.

Copyright © 2019 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.

Let’s block ads! (Why?)


No Image

Colorado Caps Insulin Co-Pays At $100 For Insured Residents

Colorado Gov. Jared Polis, pictured in January, signed a bill into law on Wednesday placing a $100 per month cap on insulin co-payments starting next year.

David Zalubowski/AP


hide caption

toggle caption

David Zalubowski/AP

As nearly 7.5 million Americans contend with covering the skyrocketing costs of insulin to manage the disease, diabetics in Colorado will soon have some relief.

A new law, signed by Gov. Jared Polis earlier this week, caps co-payments of the lifesaving medication at $100 a month for insured patients, regardless of the supply they require. Insurance companies will have to absorb the balance.

The law also directs the state’s attorney general to launch an investigation into how prescription insulin prices are set throughout the state and make recommendations to the legislature.

Colorado is the first state to enact such sweeping legislation aiming to shield patients from dramatic insulin price increases.

“One in four type 1 diabetics have reported insulin underuse due to the high cost of insulin … [t]herefore, it is important to enact policies to reduce the costs for Coloradans with diabetes to obtain life-saving and life-sustaining insulin,” the law states.

The price of the drug in the U.S. has increased exponentially in recent years. Between 2002 and 2013, it tripled, according to 2016 study published in the medical journal JAMA. It found the price of a milliliter of insulin rose from $4.34 in 2002 to $12.92 in 2013. And a March report from the House of Representatives, found “prices continued to climb, nearly doubling between 2012 and 2016.”

Dramatic price hikes have left some people with Type 1 and Type 2 diabetes who use insulin to control their blood sugar levels in the unfortunate position of making dangerous compromises. They either forego the medication or they ration their prescribed dose to stretch it until they can afford the next prescription.

In some instances, those compromises can lead to tragedy. As NPR reported, an uninsured Minnesota man who couldn’t afford to pay for $1,300 worth of diabetes supplies, died of diabetic ketoacidosis, according to his mother. The man, who was 26, had been rationing his insulin.

The move in Colorado comes on the heels of recent commitments by manufacturers to limit the drug’s cost to consumers, which in turn comes on the heels of mounting pressure (and some skewering) from elected officials.

Following a U.S. Senate Finance Committee hearing in February and a subcommittee hearing in the House in April, pharmaceutical company leaders have reluctantly admitted they have a role to play in reducing drug prices.

Last month Express Scripts, one of the largest pharmacy benefit managers in the country, announced it is launching a “patient assurance program” that will place a $25 per month cap on insulin for patients “no matter what.”

In March, insulin manufacturer Eli Lilly said it will soon offer a generic version of Humalog, called Insulin Lispro, at half the cost. That would drop the price of a single vial to $137.35.

“These efforts are not enough,” Inmaculada Hernandez of the University of Pittsburgh School of Pharmacy tells NPR, of the latest legislation in Colorado.

Hernandez was lead author of a January report in Health Affairs attributing the rising cost of prescription drugs to accumulated yearly price hikes.

While the Colorado out-of-pocket caps will likely provide financial relief for diabetes patients, she noted “the costs will kick back to all of the insured population” whose premiums are likely to go up as a result.

“Nothing is free,” Hernandez said.

“It also doesn’t fix the real issue,” she added, pointing to her own research which found “that prices have increased because there’s not enough competition in the market, demand will always be high and manufacturers leverage that to their advantage.”

Let’s block ads! (Why?)


No Image

In Midst Of Opioid Crisis, FDA May Block New Addiction Drug From Market

The drug buprenorphine blocks the cravings associated with addiction. It comes in tablets and dissolvable film. The only injectable form available is a drug called Sublocade; a rival drug is ready for market but may be blocked for several years by the FDA.

Tetra Images/Getty Images


hide caption

toggle caption

Tetra Images/Getty Images

More than 130 people in the U.S. die of an opioid overdose every day. One of the most effective ways to save lives is to get those struggling with addiction treated with medication to stop their cravings. But a loophole in federal law might block at least one new opioid-addiction drug from coming to market for years.

Many patients have to try several medications before finding one that works for them and that they can stick with.

“It’s important to have multiple different treatment options for different patients, different circumstances,” says Carolyn Bogdon, a family nurse practitioner who oversees outpatient medication-assisted treatment programs at the Medical University of South Carolina in Charleston, S.C.

Some use methadone, which they get every day. Others use Vivitrol, which can be injected once a month. And many use buprenorphine, which comes in tablets and a dissolvable film that people take once or twice a day. Buprenorphine is an opiate, but it blocks the cravings associated with addiction without giving people the same high.

A handful of patients at the university’s clinics have moved to a form of buprenorphine called Sublocade that’s injected just once a month.

And if the company that makes Sublocade gets its way, the drug will be the only long-acting buprenorphine on the market for five more years.

FDA and ‘orphan drugs’

That’s because a quirk in federal law may prevent a competing drug called Brixadi from going on sale until 2024. “It’s ready for market now,” says Mike Derkacz, CEO of Braeburn, which makes Brixadi. “We are deemed safe and effective by FDA, but we are unable to make the product available to patients during this crisis.”

Sublocade was approved for sale in 2017 and, like any new drug, was granted three years of exclusive access to U.S. markets. That time is up next year. But in December, the Food and Drug Administration told Braeburn it might have to wait four more years because Sublocade was designated an “orphan drug,” which gives it seven years of exclusive access.

Sublocade, which is made by Indivior, isn’t an orphan drug in the traditional sense. Normally, these are medications that treat illnesses affecting fewer than 200,000 people a year.

Opioid addiction is not a rare disease.

In 2017, according to the National Institute on Drug Abuse, about 2.3 million people in the U.S. were addicted to prescription opioids or illicit opiates such as heroin, and 47,000 people died of an overdose.

The Trump administration declared opioid addiction a public health emergency that same year — just a month before Sublocade hit the market — and made helping people get medication-assisted treatment a priority.

That’s why the makers of Brixadi were shocked when the FDA gave their product only tentative approval in December. Derkacz says it doesn’t make sense, in the middle of what many call an epidemic, to treat buprenorphine drugs as if they treat a rare disease.

“There have been studies that show a reduction in mortality by 40% with buprenorphine,” Braeburn’s CEO says. “That keeps people alive. That gives people a chance to get back to their lives and recover fully.”

A back-door approach

So why is Sublocade considered an orphan drug? Like many things related to prescription drugs, the reasons are wonky and sort of irrational.

Indivior created its first buprenorphine-based drug, called Subutex, in the 1990s. At the time, treating addiction with other drugs wasn’t mainstream. There were methadone clinics in some U.S. cities, but they were heavily regulated by law.

The company asked the FDA to give it orphan drug status — but instead of saying there weren’t many potential patients, Indivior said it had little hope of earning back its investment in Subutex and needed extra time with no competition. Few drugs have ever received orphan status this way. But at the time, it made sense to the FDA.

The orphan designation was granted, and Subutex hit the market in 2002.

Since then, Indivior has made billions in revenue from sales of the drug and its successors, Suboxone and Sublocade, partly because the orphan designation is automatically attached to every new formulation of buprenorphine the company makes.

Indivior’s executives declined to be interviewed for this story. But in response to written questions, the company says, “Indivior stands by FDA’s decision, which was supported by both the law and the facts at that time.”

Derkacz says Braeburn has asked the Food and Drug Administration to revoke Sublocade’s orphan status. And an FDA spokeswoman says the agency is actively considering that request.

The right drug ‘can save their life’

Long-acting, injectable treatments for addiction have some advantages over tablets and dissolvable films. Patients don’t have to remember to take medication each day, and they can avoid the drugstore.

“It provides a little bit more anonymity for patients that don’t want to disclose that they have an opiate use disorder,” says Michelle Lofwall, a psychiatrist and medical director at two University of Kentucky clinics that treat patients struggling with opioid addiction.

“Some patients have felt stigmatized when going to the pharmacy, like they don’t feel like they’re necessarily treated all that well once they show their prescription,” she says.

Lofwall participated in Brixadi’s clinical trial, so she’s one of the few health care providers who has used both medications. She says they’re slightly different and that she’d like to have the choice to offer her patients.

“From a public health perspective, and just as a provider physician trying to treat patients, they need to have all the options,” Lofwall says. Being on the right drug “literally can save their life.”

“As a clinician, it’s always important for me to have more tools,” Andrea Barthwell, an addiction treatment specialist, wrote in public comments on Braeburn’s FDA petition. “Moreover, there are gaps in care from the current buprenorphine treatment options that Brixadi may fill.”

Brixadi can be used weekly as well as monthly, allowing doctors to see their patients more frequently and monitor them more closely at the start of treatment, according to several comments.

Another issue is cost.

Sublocade costs about $1,580 per month, according to marketing materials from Indivior, and some insurance companies won’t pay for it. “In Kentucky,” Lofwall says, “we haven’t been able to get it for patients who are on several different Medicaid managed-care programs.”

By contrast, a generic version of the buprenorphine film costs about $140 a month, according to the website GoodRX.com.

Daniel Smith, who leads the medication-assisted treatment program at Mary’s Center in Washington, D.C., says he doesn’t know any doctors who use Sublocade now.

“Long-acting buprenorphine is definitely advantageous over short-acting for many reasons, but cost and availability have been the challenge,” he says.

But if a competitor drug came on the market, Smith says the price of Sublocade might fall, and he might then be willing to prescribe it to his patients.

Let’s block ads! (Why?)